ARCHIVES

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Publishes New Atlas Of Cancer Mortality

December 10, 1999

“Critical Issues” Include How U.S. NCI Spends Its Money. “Catastrophic” Cutback In Canada

May 14, 1976

Conversation with The Cancer Letter: IU’s Loehrer Discusses “Business Decision” To Close Bloomington Proton Beam Center

October 17, 2014

NCI RFA: Tobacco Use Research Centers

December 18, 1998

Levine, Mendelsohn Win Landon Awards; Ullrich Wins Pezcoller.

February 29, 2008

In Brief: CDP Awarded Contract To Do Facilities Survey; MIHICH Appointment Official; Kraybill Retires

August 24, 1984